SeeThruEquity Initiates Research Coverage on ScripsAmerica

New Post Public Reply Private Reply Replies (3) Message Board
Tutter18
SeeThruEquity Initiates Research Coverage on ScripsAmerica with a Price Target of $1.20 Go SCRC! Tut

Dec 02, 2014 (ACCESSWIRE via COMTEX) -- New York, NY / ACCESSWIRE / December 2, 2014 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has initiated coverage on ScripsAmerica, Inc. (OTCQB: SCRC) with a 12-month price target of $1.20.
The report is available here: SCRC Initiation Report. SeeThruEquity is an approved equity research contributor on Thomson First Call, Capital IQ, FactSet, and Zack's. The report will also be available on these platforms.

In our estimation ScripsAmerica is an undervalued speculative growth company in the medical industry. The company has experienced robust growth in its specialty pharmacy segment since the launch of this business, with orders that surpassed a $60mn annual run rate in October. The specialty pharmacy business specializes in compounding, or the mixing of drugs by a pharmacist to fit the unique needs of a patient. It is a high margin business that we expect can drive positive free cash flow for ScripsAmerica as soon as the second half of this year. Additionally, we see several potential catalysts over the next twelve months as the company expands its presence in specialty pharmacy and prepares for the commercial launch of a branded over-the-counter ("OTC" product called RapiMed, which is a children's pain reliever and fever reducer using the company's oral delivery technology.

"We see several potential catalysts ahead for ScripsAmerica. We expect the company to release its new RapiMed product line of acetaminophen for children's pain and fever relief utilizing its oral delivery technology in Hong Kong during the fourth quarter of 2014. Further, we suspect that investors may have overlooked the substantial operating progress made in the company's high margin specialty pharmacy business. In fact we expect this progress will enable ScripsAmerica to generate positive adjusted operating income and cash flow in the back half of the year, as was demonstrated by strong 3Q14 results released," stated Ajay Tandon, CEO of SeeThruEquity. "We are initiating coverage with a 12-month price target of $1.20 per share."

Additional investment highlights are as follows:

Specialty Pharmacy business expanding rapidly

Since launching its specialty pharmacy business in earnest after the strategic acquisition of Main Avenue Pharmacy in February, 2014, ScripsAmerica has experienced dramatic order growth, with specialty pharmacy orders reaching $5.6mn in October, demonstrating strong execution by ScripsAmerica's management team. Through Main Avenue Pharmacy, ScripsAmerica offers high margin compounding services in the form of various topical skin creams. This specialized service has many advantages for physicians, including that it provides them the ability to provide customized treatments for their patients without prescribing oral controlled narcotic medication such as vicodin or oxycontin. Indeed, ScripsAmerica has grown the business sequentially in each month since the transaction and has built a business with annualized sales of over $60mn. ScripsAmerica's management team has indicated that it has established compounding partnerships with four additional pharmacies, which could triple the number of states in which the company can operate this business, from seven to 21.

Launch of RapiMed to drive growth in 2015 and beyond

ScripsAmerica is poised to expand its business by entering the oral delivery technology (ODT) market with the launch of RapiMed, an over-the-counter children's acetaminophen product which comes in fruit flavors and uses proprietary technology to mask the bitter taste of acetaminophen. ODT is one of the fastest-growing sectors of the drug delivery market, fueled by patient demand and consumer preference of the technology over traditional tablets or liquids. The global market for ODT is increasing at double-digit rates expected to reach $13Bn in 2015. We see several potential catalysts upcoming for ScripsAmerica in this area, with the launch of the RapiMed expected by the end of the year in Hong Kong and in 1Q15E in China. Management has indicated that it expects to be able to launch the product in other geographies in 2015E, and plans to use its proprietary technology for other formulations in the future including vitamins, sleeping pills, and allergy medication, and migraines.

Please review important disclosures on our website at www.seethruequity.com.

About ScripsAmerica, Inc.

ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies.

For more information, visit www.ScripsAmerica.com.

About SeeThruEquity

SeeThruEquity is an equity research and corporate access firm focused on companies with less than $1 billion in market capitalization. The research is not paid for and is unbiased. We do not conduct any investment banking or commission based business. We are approved to contribute our research to Thomson One Analytics (First Call), Capital IQ, FactSet, Zacks and distribute our research to our database of opt-in investors. We also contribute our estimates to Thomson Estimates, the leading estimates platform on Wall Street.

For more information visit www.seethruequity.com.

Contact:

Ajay Tandon

SeeThruEquity

(646) 495-0939

SOURCE: SeeThruEquity

http://www.accesswire.com/img.ashx?id=423650

Copyright 2014 ACCESSWIRE

ScripsAmerica Inc (SCRC) Stock Research Links

SCRC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

RLX Revenue Soars, but European Margins Need Proof

Updated Category News Views 104

Revenue can wear a fancy suit while earnings arrive in work boots, and RLX Technology's third quarter is exactly that kind of report. The newly consolidated European distribution business pushed third-quarter revenue to RMB1.92 billion, up 69.7% year over year. That is a real jump, not pocket change. But the same acquisition also changed the mix, squeezed the blended...

Continue Reading
Rosenblatt Book Puts Vegas Casino Blind Spots on Display

Updated Category News Views 143

A locked casino floor is supposed to make secrets expensive. That is why the pitch behind ROSENBLATT lands with a little more weight than the usual Vegas chest-thumping: the coming memoir says Darryl Rosenblatt became a million-dollar gambler while using none of his own money, and that casino operators did not grasp the full shape of what had happened for years. Take a...

Continue Reading
Huhtamaki Maps Its 2027 Reporting Dates for Investors

Updated Category News Views 84

A calendar release rarely makes the pulse race, but it tells shareholders when the curtain will actually go up. Huhtamäki Oyj has laid out its 2027 financial reporting timetable, and the useful part is its plainness: investors now know the handful of dates when management will have to put numbers, not broad ambitions, in front of the market. For a packaging company, that...

Continue Reading
AIM Academy Accreditation Signals a Broader Quality Push

Updated Category News Views 50

Early-childhood education does not hand out many clean, easily comparable scorecards, which is precisely why AIM Academy’s new Cognia recognition deserves a closer look. The Alabama provider has earned Cognia Initial Accreditation, while its Pike Road center received Accreditation with Merit after its Initial Accreditation Review. That is not a revenue event, not a...

Continue Reading
Industrial Air Compressors: Fix, Rebuild, or Replace

Updated Category News Views 22

A compressor’s ugliest invoice is rarely the one from the service technician. It is the one nobody sees at first: a stalled production line, missed output, overtime, wasted electricity, and a maintenance crew chasing the same machine again next month. Pam Mahood of Waterloo, Iowa-based Compressed Air & Equipment Co. puts the decision where it belongs—not on the price...

Continue Reading
&honey's U.S. Beauty Awards Sweep Puts Distribution in Focus

Updated Category News Views 165

Three glossy-magazine nods may sound fluffy, but shelf momentum is never entirely fluff. Japanese haircare brand &honey says its Deep Moist Shampoo, Treatment and Hair Oil each landed 2026 recognition from Marie Claire, ELLE and Allure. For a consumer brand trying to make an American habit out of a Japanese haircare ritual, that is the sort of validation worth...

Continue Reading
Korla Kiln Gains Show How Cement Efficiency Is Won

Updated Category News Views 79

A cement kiln does not care about corporate slogans; it cares whether the flame holds, the bearings stay alive, and the feed keeps moving. That is why the work at Xinjiang Tianshan Cement's Tashidian branch in Korla deserves a closer look. This is not a glossy tale about a futuristic factory appearing overnight. It is an account of an old, unforgiving industrial process...

Continue Reading
Automus and Google Cloud Put Agents to Work on Oracle

Updated Category News Views 85

Oracle back offices are where shiny AI promises go to earn their keep, or get buried under a mountain of integrations. Automus Consulting’s newly announced collaboration with Google Cloud, unveiled November 20 at Oracle AI World, is aimed squarely at that messy middle. The firm wants to combine its Oracle implementation experience with Google Cloud infrastructure and...

Continue Reading
Lowe's Dec. 9 Conference Puts Strategy on the Clock

Updated Category News Views 167

A Calendar Entry With Real Weight December 9 is not earnings day, but it is the sort of date shareholders ought to circle anyway. Lowe's plans to hold its 2026 Analyst and Investor Conference at 8 a.m. Eastern time in New York City, with a live webcast available for those not sitting in the room. For owners of NYSE:LOW, these gatherings can be more useful than the usual...

Continue Reading
Fromm Day Marks 50 Years of Learning and Connection

Updated Category News Views 88

A city proclamation can be fluffy civic confetti, but this one lands differently. San Francisco declared Nov. 14, 2026, Fromm Day as the Fromm Institute for Lifelong Learning marked its 50th anniversary, and the underlying story is sturdier than a ceremonial photo op. A program that began in 1976 expecting roughly 50 people at an open house drew about 150 students in its...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Dynamics of the Automated Sortation System Market

Updated Category News Views 95

The Growth of the Automated Sortation System Market The automated sortation systems market is on a rapid ascent, projected to rise significantly and reach an estimated USD 5.68 billion by 2032. This thriving market, valued at approximately USD 4.00 billion in the previous year, demonstrates a vigorous compound annual growth rate (CAGR) of 3.99% from 2024 to 2032. The...

Continue Reading
Advancing Biopharmaceutical Manufacturing with New Ontologies

Updated Category News Views 148

Introducing Advanced Biopharmaceutical Manufacturing Ontologies In a groundbreaking development for the biopharmaceutical industry, the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) and Open Applications Group, Inc. (OAGi) have unveiled a set of innovative ontologies aimed at improving data interoperability and analytics. This...

Continue Reading
Illinois Tool Works Prepares for Third Quarter Earnings Call

Updated Category News Views 46

Illinois Tool Works Announces Earnings Webcast Schedule Illinois Tool Works Inc. (NYSE: ITW), a prominent name in global manufacturing, is set to release its third quarter results. The company will issue the results on a Wednesday morning at 7:00 a.m. CDT. Following this important announcement, ITW will host a webcast to discuss the outcomes and insights from their...

Continue Reading
Parry Labs Collaborates with Marines on Advanced Data Solutions

Updated Category News Views 158

Parry Labs Collaborates with Marines on Advanced Data Solutions Parry Labs, a leading defense technology firm known for its innovative hardware and digital infrastructure, has engaged with the United States Marine Corps to explore advanced data transfer techniques. During a recent demonstration involving the Joint Staff J6, Parry Labs worked on the Phantom network gateway...

Continue Reading
Discover Autonomix Medical’s Groundbreaking Presentation at EuroPCR

Updated Category News Views 122

Autonomix Medical's Innovative Contribution to EuroPCR Autonomix Medical, Inc. (NASDAQ: AMIX), a pioneering medical device company, is making waves in the field of interventional cardiology. With a focus on precision nerve-targeted treatments, the company has announced exciting developments that will be showcased in a poster presentation at the renowned EuroPCR. The Event...

Continue Reading